Cov19 FluoBolt-™ DUO SN
Summary and Explanation

Therefore, the “Cov19 FluoBoltTM-DUO SN” is your best choice for comparative assay studies.
Principle of the assay:
Anti-S1RBD and anti-NC antibodies present in serum or plasma samples from patients bind to NC-protein and the S1RBD coated onto separate metal enhanced fluorescence microtiter plates (MEF-MTP). Detection of bound antibodies is accomplished with Cy5-labelled anti-human antibodies. Calibrators with a given amount of anti-S1RBD and anti-NC antibodies are used to construct calibration curves to quantify the antibody concentration of an unknown sample.


Literature
Antibody response to SARS-CoV-2 infection in humans: A systematic review. Post N et al., PLoS One. 2020 Dec 31;15(12):e0244126.
The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients. Smits VAJ et al., Biochem Biophys Res Commun. 2021 Mar 5;543:45-49
Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals.
Brochot E. et al., Front Microbiol. 2020 Oct 19;11:584251
The SARS-CoV-2 spike protein: balancing stability and infectivity. Berger I, Schaffitzel C. Cell Res. 2020 Dec;30(12):1059-1060. doi: 10.1038/s41422-020-00430-4. PMID: 33139926; PMCID: PMC7604330
Human neutralizing antibodies elicited by SARS-CoV-2 infection. Ju B, Zhang Q, Ge J, et al. Nature. 2020 Aug;584(7819):115-119. doi: 10.1038/s41586-020-2380-z. Epub 2020 May 26. PMID: 32454513.
Application of SARS-CoV-2 Serology to Address Public Health Priorities. Sherman AC et al., Front Public Health. 2021 Nov 23;9:744535.
Silent SARS-CoV-2 Infections, Waning Immunity, Serology Testing, and COVID-19 Vaccination: A Perspective. Narasimhan M et al., Front Immunol. 2021 Sep 21;12:730404.
Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing.
Garcia-Beltran WF et al., Arch Pathol Lab Med. 2021 Apr 1;145(4):415-418.
Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic. Matta J et al.,JAMA Intern Med. 2022 Jan 1;182(1):19-25